Loading clinical trials...
Loading clinical trials...
Clinical Study of TBF Regimen in Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Central Nervous System Leukemia
Conditions
Interventions
TBF regimen
modified BuCY2 regimen
Locations
1
China
First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, China
Start Date
January 15, 2023
Primary Completion Date
December 31, 2025
Completion Date
December 31, 2025
Last Updated
December 28, 2022
NCT07101588
NCT06093867
NCT05534620
NCT06912347
NCT03719092
NCT05149365
Lead Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions